Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety Study of GL-ONC1, an Oncolytic Virus, in Patients With Advanced Solid Tumors

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by Genelux Corporation
Sponsor:
Information provided by (Responsible Party):
Genelux Corporation
ClinicalTrials.gov Identifier:
NCT00794131
First received: November 18, 2008
Last updated: March 12, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2014
  Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)